Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease

Title
Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease
Authors
Keywords
Resveratrol, Coronary artery disease, Adiponectin, Plasminogen activator inhibitor type 1 (PAI-1), Cardiovascular, Clinical trial
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 27, Issue 1, Pages 37-48
Publisher
Springer Nature
Online
2012-12-07
DOI
10.1007/s10557-012-6427-8

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation